Joint Formulary & PAD

Ezetimibe - Lipid modification

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Tablets
Associated Icons :
Restrictions / Comments :

PAD Profile

ChemicalSubstance :
Ezetimibe
Indication :
Lipid modification
Group Name :
Keywords :
primary hypercholesterolaemia, high cholesterol, raised cholesterol, familial hypercholesterolaemia, lipid-lowering, lipid lowering
Brand Names Include :
Ezetrol
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
1

Other Indications

Below are listed other indications that Ezetimibe is used to treat.

  • No records returned.

Committee Recommendations (1)

People with primary hypercholesterolaemia should be considered for ezetimibe treatment in line with TA385 (formerly TA132 superceded by TA385 in Feb 2016) - see below